ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,807Medicare Part D Prescriptions Filled, Including Refills

Rank: 102 out of 1802

$483K Total Retail Price of All Prescriptions

Rank: 102 out of 1802

413 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 413 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 413 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 6,518 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
SIMVASTATIN 495 430 1 1
OMEPRAZOLE 278 212 2 4
HYDROCODONE-ACETAMINOPHEN 275 163 S3 3 10
METFORMIN HCL 244 168 4 11
LISINOPRIL 243 205 5 3
LEVOTHYROXINE SODIUM 228 163 6 2
METOPROLOL TARTRATE 189 173 7 9
WARFARIN SODIUM 187 173 8 7
HYDROCHLOROTHIAZIDE 176 165 9 8
AMLODIPINE BESYLATE 175 138 10 6
FUROSEMIDE 156 135 11 5
CARVEDILOL 149 68 12 36
METOPROLOL SUCCINATE 143 137 13 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 134 82 14 23
GABAPENTIN 122 52 15 16
POTASSIUM CHLORIDE 118 114 16 15
ATORVASTATIN CALCIUM 109 103 17 14
ZOLPIDEM TARTRATE 103 71 18 27
PANTOPRAZOLE SODIUM 100 54 19 44
CRESTOR 97 76 20 31
PRAVASTATIN SODIUM 94 82 21 19
CITALOPRAM HBR 93 93 22 17
ATENOLOL 92 83 23 12
TAMSULOSIN HCL 91 71 24 28
METFORMIN HCL ER 84 62 25 46
TRAMADOL HCL 84 40 25 22
ALLOPURINOL 79 71 27 24
BENAZEPRIL HCL 76 64 28 61
CLOPIDOGREL 74 58 29 48
SPIRIVA 71 64 30 72
GLIPIZIDE ER 71 59 30 82
CLONIDINE HCL 70 70 32 77
NAPROXEN 70 48 32 94
PLAVIX 66 56 34 81
GLIPIZIDE XL 64 40 35 98
RANITIDINE HCL 64 51 35 30
VERAPAMIL ER 63 51 37 111
MORPHINE SULFATE ER 62 35 S2 38 71
TRAZODONE HCL 61 17 39 39
SERTRALINE HCL 59 37 40 20
LOSARTAN POTASSIUM 58 41 41 18
LOVASTATIN 54 42 42 25
ISOSORBIDE MONONITRATE ER 54 33 42 66
TRIAMCINOLONE ACETONIDE 53 34 44 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 19, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.